Results 41 to 50 of about 124,817 (274)

External radiotherapy of thyroid cancer [PDF]

open access: yes, 2001
Differentiated thyroid cancer comprises papillary, mixed papillary-follicular and follicular adenocarcinomas. They are mostly hormone-sensitive and respond to thyroid-stimulating hormone (TSH) suppression. The standard treatment is total thyroidectomy. I-
Dühmke, Eckhart, Pollinger, B.
core   +1 more source

Pediatric thyroid disease: when is surgery necessary, and who should be operating on our children? [PDF]

open access: yes, 2013
Surgical diseases of the thyroid in the pediatric population represent a diverse set of both benign and malignant conditions. Overall, incidence is rare.
Breuer, Christopher   +3 more
core   +1 more source

Medullary Thyroid Carcinoma: An Update on Imaging

open access: yesJournal of Thyroid Research, 2019
Medullary thyroid carcinoma (MTC), arising from the parafollicular C cells of the thyroid, accounts for 1–2% of thyroid cancers. MTC is frequently aggressive and metastasizes to cervical and mediastinal lymph nodes, lungs, liver, and bones.
S. Kushchayev   +5 more
semanticscholar   +1 more source

The Diagnostic Value of Ultrasound in Medullary Thyroid Carcinoma: A Comparison With Computed Tomography

open access: yesTechnology in Cancer Research & Treatment, 2020
Purpose: To explore the clinical value of ultrasound in the diagnosis of medullary thyroid carcinoma by comparing with enhanced computed tomography. Methods: This retrospective study was performed on 62 patients with pathologically confirmed medullary ...
Liang Wang MD   +5 more
doaj   +1 more source

Sorafenib in Japanese Patients with Locally Advanced or Metastatic Medullary Thyroid Carcinoma and Anaplastic Thyroid Carcinoma

open access: yesThyroid, 2017
Background: Therapeutic options for treating advanced or metastatic medullary thyroid carcinoma (MTC) and anaplastic thyroid carcinoma (ATC) are still limited in Japan, even though vandetanib for MTC and lenvatinib for MTC and ATC have been approved ...
Yasuhiro Ito   +7 more
semanticscholar   +1 more source

Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma

open access: yesAnnals of Oncology, 2017
Background Primary analysis of the double-blind, phase III Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer (EXAM) trial demonstrated significant improvement in progression-free survival with cabozantinib versus placebo in patients ...
M. Schlumberger   +18 more
semanticscholar   +1 more source

Metachronous Follicular Variant of Papillary Thyroid Microcarcinoma in a Case of Medullary Carcinoma Thyroid [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2016
Medullary carcinoma and papillary thyroid carcinoma arise from the different cells. Simultaneous occurrence of both types is rare. Medullary carcinomas are characterised by calcitonin positivity.
Neelam Sood, Binit Kumar Khandelia
doaj  

RET codon 609 mutations: a contribution for better clinical managing

open access: yesClinics, 2012
Medullary thyroid carcinoma currently accounts for 5-8% of all thyroid cancers. The clinical course of this disease varies from extremely indolent tumors that can go unchanged for years to an extremely aggressive variant that is associated with a high ...
Caterina Mian   +4 more
doaj   +1 more source

The role of molecular genetics in the clinical management of sporadic medullary thyroid carcinoma: A systematic review

open access: yesClinical Endocrinology, 2019
The significant variation in the clinical behaviour of sporadic medullary thyroid carcinoma (sMTC) causes uncertainty when planning the management of these patients.
J. Fussey   +5 more
semanticscholar   +1 more source

Calcitonin-secreting neuroendocrine neoplasms of the lung: a systematic review and narrative synthesis

open access: yesEndocrine Connections, 2021
Calcitonin-secreting neuroendocrine neoplasms of the lung are rare, with few cases reported in the literature. Differentiating between medullary th yroid carcinoma and an ectopic source of calcitonin secretion can represent a complex diagnostic conundrum
David C Llewellyn   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy